Clinical-stage pre-IPO biotech company is leveraging translational science to extend the healthy lives of beloved companions; this offering is limited to accredited investors. BOSTON, Sept. 19, 2024 /PRNewswire/ — CureLab Veterinary Inc., a pioneer in developing innovative veterinary…